This School funded position, which covers fees and a stipend at standard RCUK rates, is open to Home / EU applicant only.
1. Wood CD, Carvell T, Gunnell A, Ojeniyi OO, Osborne C, West MJ (2018). Enhancer control of miR-155 expression in Epstein-Barr virus infected B cells. Journal of Virology. Jul 18. pii: JVI.00716-18. doi: 10.1128/JVI.00716-18.
2. West, M. J. (2017). Chromatin reorganisation in Epstein Barr virus-infected cells and its role in cancer development. Current Opinion in Virology 26C pp. 149-155. doi: 10.1016/j.coviro.2017.08.004.
3. Wood CD, Veenstra H, Khasnis S, Gunnell A, Webb HM, Shannon-Lowe C, Andrews S, Osborne CS, West MJ (2016). MYC activation and BCL2L11silencing by a tumour virus through the large-scale reconfiguration of enhancer-promoter hubs. Elife. Aug 4;5. pii: e18270. doi: 10.7554/eLife.18270.
4. Gunnell, A., Webb, H. M., Wood, C. D., McClellan, M. J, Wichaidit, B., Kempkes, B., Jenner, R. G., Osborne, C., Farrell P. J., West. M. J. (2016). RUNX super-enhancer control through the Notch pathway by Epstein-Barr virus transcription factors regulates B cell growth. Nucleic Acids Research. 44, 4636-50. doi: 10.1093/nar/gkw085.
FTE Category A staff submitted: 47.61
Research output data provided by the Research Excellence Framework (REF)Click here to see the results for all UK universities